Indicators for Monitoring National Drug Policies
(1999; 250 pages) [French] View the PDF document
Table of Contents
View the documentACKNOWLEDGEMENTS
Open this folder and view contentsCHAPTER I: Introduction
Open this folder and view contentsCHAPTER II: Development of the manual
Open this folder and view contentsCHAPTER III: Model lists of indicators
Open this folder and view contentsCHAPTER IV: Methodology for indicator calculation
Open this folder and view contentsCHAPTER V: Detailed presentation of indicators
Close this folderANNEX 1: Data collection forms
View the documentData Collection Form 1 - Private drug outlets
View the documentData Collection Form 2 - Public sector drug outlets
View the documentData Collection Form 3 - Health facilities/prescribers
View the documentData Collection Form 4 - Remote health facilities
View the documentSummary Form 1 - National drug policy background information
View the documentSummary Form 2 - National drug policy structural indicators
View the documentSummary Form 3 - National drug policy process indicators
View the documentSummary Form 4 - National drug policy outcome indicators
View the documentANNEX 2: Glossary
View the documentANNEX 3: Table of random numbers
View the documentBACK COVER
 

Summary Form 3 - National drug policy process indicators

Legislation and regulation

PR1: Number of drug outlets inspected, out of total number of drug outlets in the country

N =



------------ x 100 = %

D =


PR2: Number of drug outlets in violation, out of total number of drug outlets inspected

N =



------------- x 100 = %

D =


PR3: Number of sanctions and administrative measures implemented, out of total number of violations identified

N =



------------- x 100 = %

D =


PR4: Number of samples routinely collected, out of total number of planned collected samples

N =



------------- x 100 = %

D =


PR5: Number of samples tested, out of total number of samples collected

N =



------------- x 100 = %

D =


PR6: Number of advertisements in violation of regulations on the ethical promotion of drugs, out of total number of advertisements monitored

N =



------------- x 100 = %

D =


PR7: Number of sanctions implemented for advertisements in violation of regulations, out of total number of violations identified

N =



------------- x 100 = %

D =


Essential drug selection and drug registration

PR8: Value of drugs from the national essential drugs list (EDL) procured in the public sector, out of total value of drugs procured in the same sector

N =



------------- x 100 = %

D =


PR9: Number of drugs from the national essential drugs list (EDL) prescribed, out of total number of drugs prescribed

N =



------------- x 100 = %

D =


PR10: Number of drugs from the national essential drugs list (EDL) sold, out of total number of drugs sold

N =



------------- x 100 = %

D =


PR11: Number of locally manufactured drugs sold in the country from the national essential drugs list (EDL), out of number of drugs from the national essential drugs list (EDL)

N =



------------- x 100 = %

D =


PR12: Number of combination drugs newly registered, out of total number of newly registered drugs

N =



------------- x 100 = %

D =


PR13: Number of registered drugs which are banned in other countries, out of total number of registered drugs

N =



------------- x 100 = %

D =


Drug allocation in the health budget/public sector financing policy

PR14: Value of public drug budget spent per capita in the last year, out of average value of the same budget during the past three years

N =



------------- x 100 = %

D =


PR15: Value of public drug budget spent by major hospitals, out of value of public drug budget spent

N =



------------- x 100 = %

D =


1
PR16: Value of international aid received for drugs, out of value of public drug budget

N =



------------- x 100 = %

D =


PR17: Value of revenue generated for drugs through additional financing systems, out of value of public drug budget

N =



------------- x 100 = %

D =


PR18: Public drug budget spent, out of public drug budget allocated

N =



------------- x 100 = %

D =


Public sector procurement procedures

PR19: Value of drugs purchased through competitive tender, out of value of drugs purchased

N =



------------- x 100 = %

D =


PR20: Value of drugs purchased from local manufacturers through competitive tender, out of value of drugs purchased through competitive tender

N =



------------- x 100 = %

D =


PR21: CIF/ex-factory value of a basket of drugs, out of CIF/ex-factory value of the same basket the year of reference

N =



------------- x 100 = %

D =


PR22: CIF/ex-factory value of a basket of drugs, out of "reference" value on the international market of the same basket

N =



------------- x 100 = %

D =


PR23: Average lead time for a sample of orders in the last year, out of average lead time during the past three years

N =



------------- x 100 = %

D =


PR24: Average time period of payment for a sample of orders, out of average time period of payment stated in contract

N =



------------- x 100 = %

D =


PR25: Number of drugs/batches tested, out of number of drugs/batches procured

N =



------------- x 100 = %

D =


PR26: Number of drugs/batches that failed quality control testing, out of number of drugs/batches tested

N =



------------- x 100 = %

D =


Public sector distribution and logistics

PR27: Average time between order and delivery from central store to remote facilities in the last year, out of average time between order and delivery in the past three years

N =



------------- x 100 = %

D =


PR28: Average stockout duration for a basket of drugs in the central and/or regional stores in the last year, out of average stockout duration for the same basket in the past three years

N =



------------- x 100 = %

D =


PR29: Average stockout duration for a basket of drugs in a sample of remote facilities in the last year, out of average stockout duration for the same basket in the past three years

N =



------------- x 100 = %

D =


Pricing policy

PR30: Value of a basket of drugs, out of CIF/ex-factory value of the same basket

N =



------------- x 100 = %

D =


PR31: Average expenditure per prescription, out of average expenditure per prescription in the past three years

N =



------------- x 100 = %

D =


PR32: Value of a basket of drugs, out of value of the same basket the year of reference

N =



------------- x 100 = %

D =


Information and continuing education on drug use

PR33: Number of prescribers having direct access to a (national) drug formulary, out of total number of prescribers surveyed

N =



------------- x 100 = %

D =


PR34: Number of training sessions on drug use for prescribers in the last year, out of average number of training sessions organized in the past three years

N =



------------- x 100 = %

D =


PR35: Number of prescribers who have attended at least one training session in the last year, out of total number of prescribers surveyed

N =



------------- x 100 = %

D =


PR36: Number of issues of independent drug bulletins published in the last year, out of average number of issues of independent drug bulletins published per year in the past three years

N =



------------- x 100 = %

D =


PR37: Average number of copies of independent drug bulletins sent to prescribers, out of total number of prescribers

N =



------------- x 100 = %

D =


PR38: Amount spent on public education campaigns on drug use, out of total amount spent on public health education campaigns

N =



------------- x 100 = %

D =


to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 5, 2014